Epanolol

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEpanolol
Drug Alias Nameepanolol依泮洛尔依伴洛尔epanololumTS-702 +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsMyocardial Ischemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsMyocardial Ischemia

Other Information

ATC CodeC07AB10
Related LinksWikipediaKEGG